Safer Aging With Diabetes Monitoring
About this study
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
- Condition
- Diabetes Mellitus, Type 2, Hypoglycemia
- Tested
- SAGE Group Sessions, Usual Care
- Sponsor
- Kaiser Permanente
Who can join
- Age
- 75 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 75 years
- Study condition: Diabetes Mellitus, Type 2, Hypoglycemia
- Age 75 years and older
- Diagnosis of Type 2 Diabetes
- Current treatment with insulin
- Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)
- Able to communicate in English
- Able to access email and the Internet
Exclusion 8
- On renal dialysis
- Dementia
- Pacemaker or Automatic Implantable Cardioverter Defibrillator
- Using insulin pump
- Severe Mental Illness
- Severe Visual Impairment
- In Hospice
- Current or recent CGM use
Where
6 sites, 1 recruiting
Kaiser Permanente Sacramento
Sacramento, California, United States
Kaiser Permanente Fremont
Fremont, California, United States
Kaiser Permanente San Jose
San Jose, California, United States
Kaiser Permanente San Leandro
San Leandro, California, United States
Kaiser Permanente Santa Clara
Santa Clara, California, United States
Kaiser Permanente - Union City
Union City, California, United States
Contact
-
Carolina Gonzalez
866-206-2969 Susana.C.Gonzalez@kp.org
-
Emma M Fernandez
866-206-2969 emma.m.fernandez@kp.org
Potential match only. Final eligibility is determined by the study team.